Australia markets closed

Pharming Group N.V. (PHAR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.94+0.34 (+3.54%)
As of 11:56AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
203,771
245,316
205,622
198,871
212,174
Cost of revenue
16,930
25,212
17,562
21,142
23,539
Gross profit
186,840
220,104
188,060
177,729
188,635
Operating expenses
Research development
61,323
68,914
52,531
70,369
38,519
Selling general and administrative
100,571
87,501
68,853
48,125
64,999
Total operating expenses
154,756
242,107
177,693
158,721
112,379
Operating income or loss
32,084
-22,003
10,367
19,008
76,256
Interest expense
5,603
5,964
5,358
6,091
5,944
Total other income/expenses net
-5,869
12,426
9,998
10,202
-26,859
Income before tax
34,802
-12,012
14,987
23,078
44,094
Income tax expense
4,435
-1,464
1,313
7,082
6,348
Income from continuing operations
30,367
-10,548
13,674
15,996
37,746
Net income
30,367
-10,548
13,674
15,996
37,746
Net income available to common shareholders
30,367
-10,548
13,674
15,996
37,746
Basic EPS
-0.33
-
0.21
0.25
0.58
Diluted EPS
-0.33
-
0.19
0.23
0.55
Basic average shares
66,125
-
64,868
64,201
63,627
Diluted average shares
68,269
-
70,714
70,115
68,274